In a bylined article, Litigation & Dispute Resolution partners Mark Mansour, Christopher Mikson, and associate Emily Strunk (all Washington DC) discuss a stem cell warning letter sent by the FDA signaling an increased enforcement trend.


To read this complete article visit Law360.
Downloads –